Shiny K. Kajal/LinkedIn
Mar 24, 2026, 02:55
Shiny K Kajal: FFP as a Targeted Coagulation Therapy
Shiny K. Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:
”Post 27- FFP is not just ‘something to hang.’
It’s not a fluid.
It’s not a reflex.
It’s not routine.
It is targeted coagulation therapy.
If there’s no active bleeding or significant coagulopathy,
ask yourself – what exactly are you treating?
Because every unit carries risk:
TRALI. TACO. Allergic reactions. Infection.
More plasma ≠ better outcomes.
Correction ≠ clinical benefit.
Transfuse with purpose.
Dose appropriately.
Treat the patient – not the comfort of doing something.”
Shiny K. Kajal/LinkedIn
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda